An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7p60-32 has a similar product distributed in the us, list number 7p60-21/-31.All available patient information was included.Additional patient details are not available.
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Additionally, in-house testing was completed.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A search for similar complaints did identify an increase in complaint activity for lot 55063be00, however, no related trends were identified regarding commonalities for complaint lot number and issue.In-house specificity testing was completed with complaint lot number 55063be00.All specifications were met, and no false reactive results were obtained, indicating that the specificity performance is not negatively impacted.Device history review did not identify any non-conformances or deviations with lot 55063be00 and the complaint issue.The overall performance of alinity i syphilis tp was reviewed using field data from customers worldwide.The number of standard deviation to cutoff for the negative population and the total population median value for lot 55063be00 is within the established limits and comparable to the historical performance.Additionally, the lot has a comparable or even lower initial reactive than historical reagent lot(s).No usual reagent performance was identified.Labeling was reviewed and sufficiently addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency of the alinity i syphilis tp reagent lot 55063be00 was identified.
|